Caption Management’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $513K | Buy |
+32,076
| New | +$513K | 0.01% | 324 |
|
2025
Q1 | – | Sell |
-86,760
| Closed | -$2.15M | – | 802 |
|
2024
Q4 | $2.15M | Sell |
86,760
-35,951
| -29% | -$891K | 0.02% | 114 |
|
2024
Q3 | $3.5M | Buy |
122,711
+95,275
| +347% | +$2.72M | 0.06% | 55 |
|
2024
Q2 | $724K | Sell |
27,436
-86,041
| -76% | -$2.27M | 0.01% | 173 |
|
2024
Q1 | $3.67M | Buy |
+113,477
| New | +$3.67M | 0.06% | 40 |
|
2023
Q4 | – | Sell |
-4,282
| Closed | -$164K | – | 670 |
|
2023
Q3 | $164K | Buy |
+4,282
| New | +$164K | ﹤0.01% | 316 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 576 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 584 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 749 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 718 |
|
2021
Q2 | – | Sell |
-8,600
| Closed | -$138K | – | 616 |
|
2021
Q1 | $138K | Buy |
+8,600
| New | +$138K | ﹤0.01% | 317 |
|